ThomasNet Home   |   Promote Your Business
Home  |   My ThomasNet News®  |   Industry Market Trends  |   Submit Release  |   Advertise  |   About Us May 26, 2012  

Sequenom to Present at Two Financial Conferences in September

Print | 
Email |  Comment   Share  

(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)

SEQUENOM, Inc
3595 John Hopkins Court
San Diego, CA, 92121-1331
USA



Press release date: September 2, 2010

SAN DIEGO, Sept. 2 -- Sequenom, Inc. (NASDAQ:SQNM) today announced that Ronald M. Lindsay, PhD, executive vice president of research and development, will present an overview of the company at the following conferences in September.

Rodman and Renshaw 12th Annual Healthcare Conference o Location: The Palace Hotel, New York, NY o Presentation date: Tuesday September 14, 2010 o Presentation time: 10:25am ET

UBS Global Life Sciences Conference o Location: The Grand Hyatt, New York, NY o Presentation date: Monday September 20, 2010 o Presentation time: 1:30pm ET

A live webcast and 30-day archive of these presentations will be available at http://ir.sequenom.com/.

About Sequenom

Sequenom, Inc. (NASDAQ:SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a website at http://www.sequenom.com/ to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom website to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website.

Source: Sequenom, Inc.

CONTACT: Ian Clements, PhD, Sr. Director, IR & Corporate Communications, of Sequenom, Inc., +1-858-202-9000; or Media Relations, Dan Budwick, of Pure Communications, +1-973-271-6085, for Sequenom, Inc.

Web Site: http://www.sequenom.com/ http://ir.sequenom.com/
Print | 
Email |  Comment   Share  
Contacts: View detailed contact information.


 

Post a comment about this story

Name:
E-mail:
(your e-mail address will not be posted)
Comment title:
Comment:
To submit comment, enter the security code shown below and press 'Post Comment'.
 



Start Your Free
Subscription to
Industry Market Trends.
 More New Product News from this company:
Mass Spectrometry System suits research/translational medicine studies.
Laboratory System facilitates nucleic acid analysis.
More ....
 Other News from this company:
Sequenom to Present at the Global Hunter Securities Healthcare Conference
More ....
 Tools for you
Watch Company 
View Company Profile
Company web site
More news from this company
E-Mail Story
Save Story


Home  |  My ThomasNet News®  |  Industry Market Trends  |  Submit Release  |  Advertise  |  Contact News  |  About Us
Brought to you by Thomasnet.com        Browse ThomasNet Directory

Copyright © 2012 Thomas Publishing Company
Terms of Use - Privacy Policy



Error close

Please enter a valid email address